Boston, MA, United States of America

Jeff Kovacs

This inventor holds 1 USPTO granted patent. Top assignee: Aktis Oncology, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeff Kovacs. Retrieved from https://idiyas.com/inventor/jeff-kovacs-34pj9x0a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeff Kovacs: Innovator in Oncology

Introduction

Jeff Kovacs is a notable inventor based in Boston, MA. He has made significant contributions to the field of oncology through his innovative work. His expertise and dedication have led to the development of valuable patents that aim to improve cancer treatment.

Latest Patents

Jeff Kovacs holds a patent for "B7-H3 Miniproteins, Conjugates, and Uses Thereof." This patent represents a significant advancement in the understanding and treatment of cancer. With 1 patent to his name, Kovacs continues to push the boundaries of medical research.

Career Highlights

Kovacs is currently employed at Aktis Oncology, Inc., where he applies his knowledge and skills to develop cutting-edge therapies. His work at the company focuses on innovative solutions to combat cancer, showcasing his commitment to improving patient outcomes.

Collaborations

Throughout his career, Jeff has collaborated with talented individuals such as Brian Scott Goodman and Ved Srivastava. These partnerships have fostered a creative environment that encourages the exchange of ideas and advancements in oncology.

Conclusion

Jeff Kovacs is a dedicated inventor whose work in oncology is making a difference in the fight against cancer. His innovative spirit and collaborative efforts are paving the way for future breakthroughs in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…